These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1625517)

  • 1. One brief exposure to a psychological stressor induces long-lasting, time-dependent sensitization of both the cataleptic and neurochemical responses to haloperidol.
    Antelman SM; Kocan D; Knopf S; Edwards DJ; Caggiula AR
    Life Sci; 1992; 51(4):261-6. PubMed ID: 1625517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One experience with 'lower' or 'higher' intensity stressors, respectively enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability.
    Antelman SM; Caggiula AR; Kocan D; Knopf S; Meyer D; Edwards DJ; Barry H
    Brain Res; 1991 Dec; 566(1-2):276-83. PubMed ID: 1814544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release.
    Osborne PG; O'Connor WT; Beck O; Ungerstedt U
    Brain Res; 1994 Jan; 634(1):20-30. PubMed ID: 7908848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of a single neuroleptic treatment grow with the passage of time.
    Antelman SM; Kocan D; Edwards DJ; Knopf S; Perel JM; Stiller R
    Brain Res; 1986 Oct; 385(1):58-67. PubMed ID: 3768722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K; Karcz M; Wardas J; Wolfarth S
    Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High dosage haloperidol reduces cataleptic response with increased noradrenaline metabolism in the rat brain areas].
    Takashima M; Toru M
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):149-58. PubMed ID: 6687201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-trial dopaminergic modulation of conditioned catalepsy: A single apomorphine induced increase/decrease in dopaminergic activation immediately following a conditioned catalepsy response can reverse/enhance a haloperidol conditioned and sensitized catalepsy response.
    Oliveira LR; Dias FRC; Santos BG; Silva JLL; Carey RJ; Carrera MP
    Behav Brain Res; 2016 Sep; 311():87-98. PubMed ID: 27173428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
    Banasikowski TJ; Beninger RJ
    Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
    Jaskiw GE; Bongiovanni R
    Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensification of cataleptic response in 6-hydroxydopamine-induced neurodegeneration of substantia nigra is not dependent on the degree of dopamine depletion.
    Srinivasan J; Schmidt WJ
    Synapse; 2004 Mar; 51(3):213-8. PubMed ID: 14666519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of age and isolation on the evolution of catalepsy during chronic haloperidol treatment.
    Frussa-Filho R; Otoboni JR; Uema FT; Palermo-Neto J
    Braz J Med Biol Res; 1992; 25(9):925-8. PubMed ID: 1342840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of haloperidol on changes in development of spontaneous catalepsy during subchronic injections of dopamine agonists and antagonists].
    Kozlovskiĭ VL
    Patol Fiziol Eksp Ter; 2012; (3):75-80. PubMed ID: 23072116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine potentiates the behavioral effects of haloperidol.
    Emerich DF; Norman AB; Sanberg PR
    Psychopharmacol Bull; 1991; 27(3):385-90. PubMed ID: 1775613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen.
    Yoshida Y; Ono T; Kawano K; Miyagishi T
    Brain Res; 1994 Mar; 639(1):139-48. PubMed ID: 7910107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine metabolites and catalepsy after lithium and haloperidol.
    Bowers MB; Rozitis A
    Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine or haloperidol 2 weeks earlier antagonized the plasma corticosterone response to amphetamine; evidence for the stressful/foreign nature of drugs.
    Antelman SM; Caggiula AR; Knopf S; Kocan DJ; Edwards DJ
    Psychopharmacology (Berl); 1992; 107(2-3):331-6. PubMed ID: 1615134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.
    Ushijima I; Mizuki Y; Yamada M
    Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.